Company

Trevi Therapeutics, Inc.

Trevi Therapeutics is a clinical-stage biopharmaceutical company developing Haduvio for chronic cough, based in New Haven, US.

About

Founded in 2011 and based in New Haven, US, Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing its investigational product Haduvio for chronic cough caused by idiopathic pulmonary fibrosis and refractory chronic cough. Jennifer Good is CEO and founder. The company has raised a total of USD 55.00 mn, including a PIPE on May 7, 2019, and has completed 8 deals in total. Its stage is recorded as Public.

6Funding rounds

7Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in